[{"address1": "18105 SE Mill Plain Boulevard", "city": "Vancouver", "state": "WA", "zip": "98683", "country": "United States", "phone": "360 949 1041", "website": "https://www.absci.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.", "fullTimeEmployees": 193, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean  McClain", "age": 32, "title": "Founder, CEO, President & Director", "yearBorn": 1990, "fiscalYear": 2022, "totalPay": 936200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zachariah  Jonasson Ph.D.", "age": 49, "title": "Chief Business Officer, CFO & Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 98300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andreas  Busch Ph.D.", "age": 59, "title": "Chief Innovation Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 1562650, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Todd  Bedrick CPA", "title": "Senior VP & Chief Accounting Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Khan CPA", "title": "VP of Finance & Head of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack  Gold", "title": "Chief Marketing Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Karin  Wierinck", "title": "Chief People Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Melissa  Patterson Ph.D.", "title": "Chief of Staff", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jens  Plassmeier Ph.D.", "title": "Senior VP of Biologics Discovery Technology", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wen  Sha", "title": "Chief of Staff", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.0, "open": 4.17, "dayLow": 4.05, "dayHigh": 5.2256, "regularMarketPreviousClose": 4.0, "regularMarketOpen": 4.17, "regularMarketDayLow": 4.05, "regularMarketDayHigh": 5.2256, "payoutRatio": 0.0, "beta": 1.543, "forwardPE": -6.472973, "volume": 3299092, "regularMarketVolume": 3299092, "averageVolume": 613670, "averageVolume10days": 1373180, "averageDailyVolume10Day": 1373180, "bid": 0.0, "ask": 0.0, "bidSize": 1100, "askSize": 900, "marketCap": 445175392, "fiftyTwoWeekLow": 1.111, "fiftyTwoWeekHigh": 5.2256, "priceToSalesTrailing12Months": 64.17405, "fiftyDayAverage": 1.7966, "twoHundredDayAverage": 1.6942, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 349444320, "profitMargins": 0.0, "floatShares": 60941618, "sharesOutstanding": 92938496, "sharesShort": 2309896, "sharesShortPriorMonth": 2463443, "sharesShortPreviousMonthDate": 1698710400, "dateShortInterest": 1701302400, "sharesPercentSharesOut": 0.0249, "heldPercentInsiders": 0.25136998, "heldPercentInstitutions": 0.36228, "shortRatio": 6.38, "shortPercentOfFloat": 0.0428, "impliedSharesOutstanding": 92938496, "bookValue": 2.113, "priceToBook": 2.2669191, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -106492000, "trailingEps": -1.16, "forwardEps": -0.74, "pegRatio": -0.12, "enterpriseToRevenue": 50.374, "enterpriseToEbitda": -4.617, "52WeekChange": 0.78571427, "SandP52WeekChange": 0.24042678, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ABSI", "underlyingSymbol": "ABSI", "shortName": "Absci Corporation", "longName": "Absci Corporation", "firstTradeDateEpochUtc": 1626960600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "cfcaddfc-dbcf-384a-9b76-cf40fa9f292c", "messageBoardId": "finmb_266013918", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.79, "targetHighPrice": 4.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.67, "targetMedianPrice": 4.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 113479000, "totalCashPerShare": 1.221, "ebitda": -75683000, "totalDebt": 17748000, "quickRatio": 4.085, "currentRatio": 4.816, "totalRevenue": 6937000, "debtToEquity": 9.036, "revenuePerShare": 0.076, "returnOnAssets": -0.19493, "returnOnEquity": -0.43523, "freeCashflow": -37539124, "operatingCashflow": -68282000, "revenueGrowth": -0.686, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -31.32124, "financialCurrency": "USD", "trailingPegRatio": null}]